How to manage the costs of adverse events in a CE analysis?
Have you already performed health economic analyses? Then you will definitely recognise the following. To what level is it relevant to include costs in the analysis? For quite a few parameters, it is clear that they can have a decisive influence on your analysis and in your decision-making process. However, sometimes the effort you have […]
Clinical data, the key to a good market access dossier
The chicken or the egg. It’s a question that keeps many busy. The budget can be synonymous with the chicken and innovations synonymous with the egg (or the other way around, of course …). Anyway, any kind of innovation results in shifts in resources (lower consumption, higher efficacy, fewer side effects). For pharmaceuticals, it is […]
How to measure the value of innovation?
How to measure health benefits? Within healthcare, there is continuous innovation. New technologies are made available and (partly) replace existing resources or care. But how can you measure the financial value of innovation? It is not because a diagnostic device has 10 x sharper imaging that also a ten-fold health gain will be achieved, let […]
How to determine a correct price for innovation?
What is innovation? According to Wikipedia: “Innovation is the practical implementation of ideas that result in the introduction of new goods or services or improvement in offering goods or services. ISO TC 279 on innovation management proposes in the standards, ISO 56000:2020 to define innovation as “a new or changed entity creating or redistributing value“. […]
Introduction – Market Access
Here we are; nice to meet you. How can you ensure optimal market access for your innovation? Act like we do: be prepared and share the knowledge as you would like to receive it yourself. Sharing experience, knowledge and expertise is part of our company culture, and so we are happy to share this with […]